Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 12201-12250 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04829383
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
PHASE2Active, not recruiting
50 participants
Started: Mar 22, 2021 · Completed: Oct 31, 2025
1 condition3 sponsors7 locations
NCT04827368
Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease
N/AActive, not recruiting
292 participants
Started: Mar 22, 2021 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT04965155
A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)
PHASE2Active, not recruiting
50 participants
Started: Mar 21, 2021 · Completed: Mar 31, 2027
1 condition1 sponsor14 locations
NCT04727788
Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
N/AActive, not recruiting
550 participants
Started: Mar 21, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor13 locations
NCT04790344
LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
NAActive, not recruiting
525 participants
Started: Mar 20, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor56 locations
NCT04902781
Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia
PHASE2/PHASE3Active, not recruiting
47 participants
Started: Mar 20, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor3 locations
NCT04833348
Quantification of Motor Function in Infants With Spinal Muscular Atrophy Treated With Innovative Therapies
NAActive, not recruiting
35 participants
Started: Mar 20, 2021 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT04621188
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
PHASE2Active, not recruiting
54 participants
Started: Mar 19, 2021 · Completed: Feb 28, 2027
1 condition1 sponsor34 locations
NCT04455841
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
PHASE1/PHASE2Active, not recruiting
84 participants
Started: Mar 19, 2021 · Completed: Nov 26, 2027
3 conditions1 sponsor34 locations
NCT04799054
A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
188 participants
Started: Mar 18, 2021 · Completed: Mar 31, 2026
7 conditions1 sponsor49 locations
NCT04784247
Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma
PHASE2Active, not recruiting
52 participants
Started: Mar 18, 2021 · Completed: Mar 31, 2026
1 condition3 sponsors7 locations
NCT04791033
Quality of Life After Hysterectomy (AdenoQOL)
N/AActive, not recruiting
218 participants
Started: Mar 18, 2021 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT04823143
Natural History Study of Patients With VCP-related Disease
N/AActive, not recruiting
44 participants
Started: Mar 18, 2021 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT04691804
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE3Active, not recruiting
496 participants
Started: Mar 18, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor147 locations
NCT04387227
Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2Active, not recruiting
22 participants
Started: Mar 18, 2021 · Completed: Jun 1, 2026
3 conditions3 sponsors1 location
NCT04837716
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer
PHASE1Active, not recruiting
12 participants
Started: Mar 18, 2021 · Completed: Sep 23, 2027
6 conditions1 sponsor1 location
NCT05360706
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
N/AActive, not recruiting
9 participants
Started: Mar 18, 2021 · Completed: May 31, 2026
1 condition1 sponsor6 locations
NCT04586530
Telehealth and Memory Study
NAActive, not recruiting
220 participants
Started: Mar 18, 2021 · Completed: May 31, 2026
1 condition2 sponsors2 locations
NCT04819308
Differences in Nutrient Use During Exercise Between Children of Varying Body Mass Indices and Fitness Levels
N/AActive, not recruiting
95 participants
Started: Mar 18, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04756037
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
PHASE3Active, not recruiting
1,020 participants
Started: Mar 18, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor112 locations
NCT04586010
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
PHASE3Active, not recruiting
746 participants
Started: Mar 17, 2021 · Completed: Nov 30, 2027
1 condition1 sponsor160 locations
NCT03902951
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
PHASE2Active, not recruiting
28 participants
Started: Mar 17, 2021 · Completed: Jan 1, 2027
4 conditions2 sponsors1 location
NCT04702880
A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
PHASE2Active, not recruiting
120 participants
Started: Mar 17, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor39 locations
NCT04713475
Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis
PHASE1/PHASE2Active, not recruiting
26 participants
Started: Mar 17, 2021 · Completed: Feb 28, 2029
4 conditions1 sponsor7 locations
NCT04216290
A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial
PHASE2Active, not recruiting
95 participants
Started: Mar 17, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor216 locations
NCT04817774
Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients
PHASE1/PHASE2Active, not recruiting
26 participants
Started: Mar 17, 2021 · Completed: Oct 29, 2025
2 conditions1 sponsor5 locations
NCT04654468
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition
PHASE3Active, not recruiting
51 participants
Started: Mar 17, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT04711915
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
PHASE1Active, not recruiting
30 participants
Started: Mar 17, 2021 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT04562870
A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis
PHASE2Active, not recruiting
112 participants
Started: Mar 17, 2021 · Completed: Sep 30, 2026
1 condition1 sponsor21 locations
NCT04440657
Self-assured Parents - a Parenting Support Program for Immigrant Parents With Teenage Children Living in Deprived Areas
NAActive, not recruiting
16 participants
Started: Mar 17, 2021 · Completed: Jun 30, 2024
3 conditions3 sponsors1 location
NCT04594772
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
PHASE2Active, not recruiting
32 participants
Started: Mar 17, 2021 · Completed: Jan 1, 2026
1 condition1 sponsor2 locations
NCT04394858
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
PHASE2Active, not recruiting
46 participants
Started: Mar 17, 2021 · Completed: Feb 28, 2026
8 conditions1 sponsor163 locations
NCT04487756
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Mar 17, 2021 · Completed: Oct 31, 2024
1 condition3 sponsors3 locations
NCT04724980
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
PHASE1/PHASE2Active, not recruiting
38 participants
Started: Mar 16, 2021 · Completed: Jun 5, 2026
3 conditions2 sponsors1 location
NCT04687358
REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients
N/AActive, not recruiting
500 participants
Started: Mar 16, 2021 · Completed: Feb 28, 2026
1 condition2 sponsors29 locations
NCT04743167
IVF Versus Surgery for Endometriosis Related Infertility
NAActive, not recruiting
206 participants
Started: Mar 16, 2021 · Completed: Dec 31, 2025
1 condition4 sponsors3 locations
NCT04708769
Elements Vital to Treat Obesity Study
NAActive, not recruiting
524 participants
Started: Mar 16, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04796493
Objective Grading of MTS With LSCI and Thermography
N/AActive, not recruiting
98 participants
Started: Mar 16, 2021 · Completed: Aug 23, 2027
1 condition1 sponsor1 location
NCT04657094
Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia
PHASE2Active, not recruiting
4 participants
Started: Mar 16, 2021 · Completed: Feb 27, 2026
4 conditions2 sponsors1 location
NCT04670224
Efficiency of the Quadratus Lumborum Block for Post-operative Analgesia in Abdominoplasty Surgery
NAActive, not recruiting
286 participants
Started: Mar 16, 2021 · Completed: Jan 31, 2026
4 conditions1 sponsor1 location
NCT06133049
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
N/AActive, not recruiting
2,961 participants
Started: Mar 16, 2021 · Completed: Aug 31, 2031
1 condition1 sponsor1 location
NCT04407767
A Case Formulation Approach to Cognitive Processing Therapy
NAActive, not recruiting
179 participants
Started: Mar 15, 2021 · Completed: Sep 1, 2026
1 condition1 sponsor8 locations
NCT04019015
Prehospital Kcentra for Hemorrhagic Shock
PHASE2Active, not recruiting
166 participants
Started: Mar 15, 2021 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT04708041
Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)
PHASE3Active, not recruiting
700 participants
Started: Mar 15, 2021 · Completed: Oct 23, 2029
1 condition1 sponsor30 locations
NCT04685967
Clinical Evaluation of a Restorative Glass Ionomer and a Bulk-fill Composite Resin
NAActive, not recruiting
23 participants
Started: Mar 15, 2021 · Completed: May 1, 2025
1 condition1 sponsor1 location
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
PHASE2Active, not recruiting
9 participants
Started: Mar 15, 2021 · Completed: May 31, 2026
1 condition1 sponsor6 locations
NCT04805918
Pedagogues Promoting Positive Parenting in a Home-visiting Program in At-risk Families: A RCT of VIPP-SD
NAActive, not recruiting
130 participants
Started: Mar 15, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04759248
Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
PHASE2Active, not recruiting
55 participants
Started: Mar 15, 2021 · Completed: Jul 1, 2027
1 condition2 sponsors15 locations
NCT04235816
Improving Care Through Azithromycin Research for Infants in Africa
PHASE3Active, not recruiting
20,560 participants
Started: Mar 15, 2021 · Completed: Apr 30, 2026
1 condition5 sponsors1 location
NCT04639050
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease
PHASE1/PHASE2Active, not recruiting
285 participants
Started: Mar 15, 2021 · Completed: Jun 30, 2030
1 condition1 sponsor44 locations